未登录 A plain language summary of the TROPHY-U-01 study (Cohort 2): use of sacituzumab govitecan after immunotherapy in people with metastatic urothelial cancer who cannot take cisplatin-based chemotherapy TROPHY-U-01研究（队列2）的通俗总结：在无法接受顺铂为基础化疗的转移性尿路上皮癌患者中，免疫疗法后使用sacituzumab govitecan的疗效。 Grivas, Petros; Tagawa, Gurdeep; Jain, Rohit K.; Bupathi, Manojkumar; Balar, Arjun; Rezazadeh Kalebasty, Arash; George, Saby; Palmbos, Phillip; Nordquist, Luke; Petrylak, Daniel P.; Davis, Nancy; Sternberg, Cora N.; Agarwal, Neeraj; Park, Chandler; Tonelli, Julia; Zhou, Huafeng; Bangs, Rick; Loriot, Yohann 分享 收藏
分享 收藏
分享 收藏
Phase 1b/2 study of batiraxcept alone and in combination with cabozantinib with or without nivolumab for advanced clear cell renal cell carcinoma I期b/II期研究：评估batiraxcept单药及联合cabozantinib（无论是否联合nivolumab）治疗晚期透明细胞肾细胞癌的疗效。 Beckermann, Kathryn E.; Shah, Neil J.; Campbell, Matthew T.; Haas, Naomi B.; Nelson, Ariel; Ornstein, Moshe C.; Mao, Shifeng; Keshava-Prasad, Holavanahalli S.; Hammers, Hans; Gao, Xin; Gourdin, Theodore; George, Saby; Hoimes, Christopher J.; Hussain, Arif; Jonasch, Eric; Rini, Brian, I; Voss, Martin H. 分享 收藏
Alkaline phosphatase decline and pain response as predictors of overall survival benefit in patients treated with radium-223: a post hoc analysis of the REASSURE study O'Sullivan, Joe M.; Heinrich, Daniel; Castro, Elena; George, Saby; Dizdarevic, Sabina; Baldari, Sergio; Essler, Markus; Jong, Igle Jan de; Lastoria, Secondo; Hammerer, Peter G.; Tombal, Bertrand; James, Nicholas D.; Meltzer, Jeff; Sandstrom, Per; Sartor, Oliver 分享 收藏
Three- and Seven-month Prostate-specific Antigen Levels as Prognostic Markers for Overall Survival in Metastatic Hormone- sensitive Prostate Cancer: Results from SWOG S1216, a Phase 3 Randomized Trial of Androgen Deprivation Plus Orteronel or Bicalutamide 3个月和7个月的前列腺特异性抗原水平可作为转移性激素敏感性前列腺癌总生存期的预后指标: SWOG S1216的结果，这是一项雄激素剥夺加Orteronel或比卡鲁胺的3期随机试验 Parikh, Mamta; Tangen, Catherine; Hussain, Maha H. A.; Gupta, Shilpa; Callis, Sam; Jo, Yeonjung; Harzstark, Andrea; Paller, Channing J.; George, Saby; Zibelman, Matthew R.; Cheng, Heather H.; Maughan, Benjamin L.; Zhang, Jingsong; Pachynski, Russell K.; Bryce, Alan H.; Lin, Daniel W.; Quinn, David I.; Lerner, Seth P.; Thompson, Ian M.; Dorff, Tanya B.; Lara, Primo N.; Agarwal, Neeraj 分享 收藏
Baseline characteristics, safety, and efficacy of Radium-223 in metastatic castration resistant prostate cancer by race: Insights from the REASSURE US subset Conti, Peter S.; Sartor, Oliver; Taplin, Mary-Ellen; Song, Daniel Y.; George, Saby; Tomaszewski, Jeffrey; Sylvester, John; Mantz, Constantine; Given, Robert W.; Brookland, Robert; Meltzer, Jeff; Korn, Matthew J.; Andres, Richard; Babajanyan, Svetlana; Higano, Celestia 分享 收藏
Nivolumab plus cabozantinib versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended follow-up from the phase III randomised CheckMate 9ER trial Nivolumab联合卡博替尼与舒尼替尼一线治疗晚期肾细胞癌: III期随机CheckMate 9ER试验的延长随访 Powles, T.; Burotto, M.; Escudier, B.; Apolo, A. B.; Bourlon, M. T.; Shah, A. Y.; Suarez, C.; Porta, C.; Barrios, C. H.; Richardet, M.; Gurney, H.; Kessler, E. R.; Tomita, Y.; Bedke, J.; George, S.; Scheffold, C.; Wang, P.; Fedorov, V.; Motzer, R. J.; Choueiri, T. K. 分享 收藏
Phase II Trial of Concurrent Nivolumab and Radiation Therapy for Muscle-Invasive Bladder Cancer of Older or Chemotherapy-Ineligible Patients Vaishampayan, Ulka N.; Heilbrun, Lance; Vaishampayan, Nitin; Harper, Felicity W. K.; Shi, Dongping; Smith, Daryn; Green, Kelly; Guru, Khurshid; Li, Qiang; Kuettel, Michael; Chatta, Gurkamal; Maier, Jordan; Dickow, Brenda; Moore, Tanina Foster; George, Saby 分享 收藏
Safety and effectiveness of the radium-223-taxane treatment sequence in patients with metastatic castration-resistant prostate cancer in a global observational study (REASSURE) Higano, Celestia S.; Dizdarevic, Sabina; Logue, John; Richardson, Timothy; George, Saby; de Jong, Igle; Tomaszewski, Jeffrey J.; Saad, Fred; Miller, Kurt; Meltzer, Jeffrey; Sandstroem, Per; Verholen, Frank; Tombal, Bertrand; Sartor, Oliver 分享 收藏
Kidney Cancer, Version 2.2024 Featured Updates to the NCCN Guidelines Motzer, Robert J.; Jonasch, Eric; Agarwal, Neeraj; Alva, Ajjai; Bagshaw, Hilary; Baine, Michael; Beckermann, Kathryn; Carlo, Maria I.; Choueiri, Toni K.; Costello, Brian A.; Derweesh, Ithaar H.; Desai, Arpita; Ged, Yasser; George, Saby; Gore, John L.; Gunn, Andrew; Haas, Naomi; Johnson, Michael; Kapur, Payal; King, Jennifer; Kyriakopoulos, Christos; Lam, Elaine T.; Lara, Primo N.; Lau, Clayton; Lewis, Bryan; Madoff, David C.; Manley, Brandon; Michaelson, M. Dror; Mortazavi, Amir; Ponsky, Lee; Ramalingam, Sundhar; Shuch, Brian; Smith, Zachary L.; Sosman, Jeffrey; Sweis, Randy; Zibelman, Matthew; Schonfeld, Ryan; Stein, MaryElizabeth; Gurski, Lisa A. 分享 收藏
Phase Ib/II study of batiraxcept (BT, AVB-S6-500, an AXL pathway inhibitor) in combination with cabozantinib (cabo) in patients with advanced clear cell renal cell carcinoma (ccRCC) who failed first-line (1L) therapy Shah, N. J.; Campbell, M. T.; Mao, S.; Ornstein, M. C.; Haas, N. B.; Gao, X.; Hammers, H.; Keshava-Prasad, H.; Hoimes, C. J.; Hussain, A.; George, S.; Gourdin, T. S.; Nelson, A.; Yan, H.; Esquibel, V.; McIntyre, G.; Geller, R.; Voss, M. H.; Rini, B. I.; Beckermann, K. 分享 收藏
Study EV-103 cohort L: Perioperative treatment w/ enfortumab vedotin (EV) monotherapy in cisplatin (cis)ineligible patients (pts) w/ muscle invasive bladder cancer (MIBC) Sridhar, S.; O'Donnell, P. H.; Flaig, T. W.; Rosenberg, J. E.; Hoimes, C. J.; Milowsky, M. I.; Srinivas, S.; George, S.; McKay, R. R.; Petrylak, D. P.; Barata, P. M. Coelho; Hwang, C.; Cruz-Correa, M.; Iafolla, M.; Mckean, M.; Dreicer, R.; Brancato, S.; Lukas, J. J.; Yu, Y.; Moon, H. 分享 收藏
Summary of Research: Adjuvant Nivolumab Plus Ipilimumab Versus Placebo for Localized Renal Cell Carcinoma After Nephrectomy (CheckMate 914): A Double-Blind, Randomized, Phase 3 Trial Motzer, Robert J.; Russo, Paul; Gruenwald, Viktor; Tomita, Yoshihiko; Zurawski, Bogdan; Parikh, Omi; Buti, Sebastiano; Barthelemy, Philippe; Goh, Jeffrey C.; Ye, Dingwei; Lingua, Alejo; Lattouf, Jean-Baptiste; Albiges, Laurence; George, Saby; Shuch, Brian; Sosman, Jeffrey; Staehler, Michael; Vazquez Estevez, Sergio; Simsek, Burcin; Spiridigliozzi, Julia; Chudnovsky, Aleksander; Bex, Axel 分享 收藏
Metastatic renal cell carcinoma to the pancreas and other sites -a multicenter retrospective study Duarte, Cassandra; Hu, Junxiao; Beuselinck, Benoit; Panian, Justine; Weise, Nicole; Dizman, Nazli; Collier, Katharine A.; Rathi, Nityam; Li, Haoran; Elias, Roy; Martinez-Chanza, Nieves; Rose, Tracy L.; Harshman, Lauren C.; Gopalakrishnan, Dharmesh; Vaishampayan, Ulka; Zakharia, Yousef; Narayan, Vivek; Carneiro, Benedito A.; Mega, Anthony; Singla, Nirmish; Meguid, Cheryl; George, Saby; Brugarolas, James; Agarwal, Neeraj; Mortazavi, Amir; Pal, Sumanta; McKay, Rana R.; Lam, Elaine T. 分享 收藏
Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial Motzer, Robert J.; Russo, Paul; Gruenwald, Viktor; Tomita, Yoshihiko; Zurawski, Bogdan; Parikh, Omi; Buti, Sebastiano; Barthelemy, Philippe; Goh, Jeffrey C.; Ye, Dingwei; Lingua, Alejo; Lattouf, Jean-Baptiste; Albiges, Laurence; George, Saby; Shuch, Brian; Sosman, Jeffrey; Staehler, Michael; Vazquez Estevez, Sergio; Simsek, Burcin; Spiridigliozzi, Julia; Chudnovsky, Aleksander; Bex, Axel 分享 收藏
分享 收藏
FRACTION-RCC: nivolumab plus ipilimumab for advanced renal cell carcinoma after progression on immuno-oncology therapy 分数-RCC: nivolumab联合ipilimumab治疗免疫肿瘤治疗进展后的晚期肾细胞癌 Choueiri, Toni K.; Kluger, Harriet; George, Saby; Tykodi, Scott S.; Kuzel, Timothy M.; Perets, Ruth; Nair, Suresh; Procopio, Giuseppe; Carducci, Michael A.; Castonguay, Vincent; Folefac, Edmund; Lee, Chung-Han; Hotte, Sebastien J.; Miller, Wilson H.; Saggi, Shruti Shally; Lee, Chung-Wei; Desilva, Heshani; Bhagavatheeswaran, Prabhu; Motzer, Robert J.; Escudier, Bernard 分享 收藏
Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor response in metastatic renal cell carcinoma Brown, Landon C.; Zhu, Jason; Desai, Kunal; Kinsey, Emily; Kao, Chester; Lee, Yong Hee; Pabla, Sarabjot; Labriola, Matthew K.; Tran, Jennifer; Dragnev, Konstantin H.; Tafe, Laura J.; Dayyani, Farshid; Gupta, Rajan T.; McCall, Shannon; George, Daniel J.; Glenn, Sean T.; Nesline, Mary K.; George, Saby; Zibelman, Matthew; Morrison, Carl; Ornstein, Moshe C.; Zhang, Tian 分享 收藏
Analysis of long-term efficacy outcomes from the CheckMate 025 (CM 025) trial comparing nivolumab (NIVO) vs everolimus (EVE) based on ≥ 7 years (yrs) of follow-up in pre-treated patients (pts) with advanced renal cell carcinoma (aRCC) Escudier, B.; Motzer, R. J.; Dyer, M.; May, J. R.; Ejzykowicz, F.; Kurt, M.; Lee, C-W.; Wang, P.; Testa, E.; Sharpe, D. J.; George, S.; Tannir, N. 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
FUTURE ONCOLOGY.png)
OAAI
.png){kind=icon}
分享.png){kind=icon}
收藏
OAAI